focus -WSS

focus

author：hotspot 2025-09-30 21:57:17 - browse：5

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： 'Screen and refer' systems are hurting patients

WSS

Ascension's ugly legal battle over care for poor patients in Texas

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Gene therapy denied for Afghan refugee whose father aided U.S.

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Beware reading your test results before your doctor does

hotspot

focus

hotspot

How one medical school became remarkably diverse

Male doctors called my cancer incurable. A female doctor showed it wasn't

23andMe had bad news about my health. I wish a person had delivered it

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Dexcom's push to bring CGM to type 2 diabetes patients

Apple is now the first public company to be valued at $3 trillion

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Anesthesiologist group: stop taking Ozempic before surgery

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

focus

STAT wants to know your pick for a great summer read or listen

Dexcom's push to bring CGM to type 2 diabetes patients

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Allen Institute goes after foundational questions, CEO Costa says

Hubble vs. James Webb telescope images: See the difference

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

entertainment

focus

focus

leisure time